BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1410877)

  • 1. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G; Weber JC; Sachs D; Korganow AS; Martin T; Kretz JG; Pasquali JL
    Rev Med Interne; 1992; 13(1):61-3. PubMed ID: 1410877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].
    Meier C; Stey C; Brack T; Maggiorini M; Risti B; Krähenbühl S
    Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1342-6. PubMed ID: 7624744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-interaction-induced rhabdomyolysis.
    Segaert MF; De Soete C; Vandewiele I; Verbanck J
    Nephrol Dial Transplant; 1996 Sep; 11(9):1846-7. PubMed ID: 8918636
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.
    Chariot P; Abadia R; Agnus D; Danan C; Charpentier C; Gherardi RK
    Am J Med; 1993 Jan; 94(1):109-10. PubMed ID: 8420287
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis associated with simvastatin-gemfibrozil therapy.
    Tal A; Rajeshawari M; Isley W
    South Med J; 1997 May; 90(5):546-7. PubMed ID: 9160078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I; Spinler SA; Johnson NE
    Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductase inhibitor therapy of hypercholesterolemia.
    Kreisberg RA
    Trans Am Clin Climatol Assoc; 1991; 102():153-63; discussion 163-5. PubMed ID: 2130558
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors.
    Sirtori CR
    Pharmacol Ther; 1993 Dec; 60(3):431-59. PubMed ID: 8073070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin.
    Arnadottir M; Eriksson LO; Thysell H; Karkas JD
    Nephron; 1993; 65(3):410-3. PubMed ID: 8289991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simvastatin].
    Burgmer U; Mohr K
    Dtsch Med Wochenschr; 1996 Jun; 121(23):769-70. PubMed ID: 8646995
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Garnett WR
    Am J Health Syst Pharm; 1995 Aug; 52(15):1639-45. PubMed ID: 7583826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical tolerance of lovastatin and simvastatin.
    Bilheimer DW
    Cardiology; 1990; 77 Suppl 4():58-65. PubMed ID: 2073673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M; Eriksson LO; Germershausen JI; Thysell H
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
    Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
    Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and simvastatin.
    Deslypere JP; Vermeulen A
    Ann Intern Med; 1991 Feb; 114(4):342. PubMed ID: 1987887
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions.
    Kusus M; Stapleton DD; Lertora JJ; Simon EE; Dreisbach AW
    Am J Med Sci; 2000 Dec; 320(6):394-7. PubMed ID: 11149552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive rhabdomyolysis and simvastatin.
    Bizzaro N; Bagolin E; Milani L; Cereser C; Finco B
    Clin Chem; 1992 Aug; 38(8 Pt 1):1504. PubMed ID: 1643724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.